Page last updated: 2024-08-24

2,4-diaminopyrimidine and Lymphoma, Large-Cell, Anaplastic

2,4-diaminopyrimidine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aimone, LD; Albom, MS; Angeles, TS; Anzalone, AV; Ator, MA; Burke, JP; Cheng, M; Dorsey, BD; Dugan, BJ; Huang, Z; Lu, L; Mesaros, EF; Ott, GR; Parrish, JD; Quail, MR; Ruggeri, BA; Wan, W	1

Other Studies

1 other study(ies) available for 2,4-diaminopyrimidine and Lymphoma, Large-Cell, Anaplastic

Article	Year
Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models. Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1 Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Benzazepines; Lymphoma, Large-Cell, Anaplastic; Mice; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Xenograft Model Antitumor Assays	2011

Article

Year

Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models.

Bioorganic & medicinal chemistry letters, 2011, Jan-01, Volume: 21, Issue:1

Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Benzazepines; Lymphoma, Large-Cell, Anaplastic; Mice; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Xenograft Model Antitumor Assays

2011